ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 697 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Nirogacestat May Offer Hope to People with Desmoid Tumors May 1, 2023 Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate... December 11, 2025 Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among... August 25, 2025 Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and... June 3, 2025 Load more HOT NEWS How to Clean Your Home When Caring for Someone With Cancer Only a Quarter of Phase III Studies Demonstrated Improved QoL in... Understanding the Risk of Second Cancers After CAR T-Cell Therapy “Your Stories” Podcast: Amplifying Patient Voices
